Stockreport

City of Hope-developed Chimeric Antigen Receptor (CAR) T Cell Therapy Shows Clinical Activity in Patients With Aggressive Brain Tumors in a Phase 1 Trial [Yahoo! Finance]

Mustang Bio, Inc.  (MBIO) 
Last mustang bio, inc. earnings: 11/12 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: mustangbio.com/investor-relations
PDF Nature Medicine paper highlights delivery of CAR T cell therapy directly to the brain, a technique City of Hope developed This is the largest reported trial to date o [Read more]